Second generation oral hypoglycemic agents.
Keller
J T
JT
D000284:Administration, Oral; D002386:Cataract / Q000139:chemically induced; D003920:Diabetes Mellitus / Q000188:drug therapy; D005905:Glyburide / Q000009:adverse effects*; D006801:Humans; D006956:Hyperopia / Q000139:chemically induced*; D007908:Lens, Crystalline / Q000187:drug effects
D005905:Glyburide